This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system. The evaluations will include clinical assessments, neurologic exams, patient reported outcome surveys, and skin biopsies from three locations. Data will be collected on the amount of P-SYN in cutaneous nerve fibers. The cohorts of interest are as follows: 1. 100 participants with Long COVID-19 defined by NIH PASC criteria 2. 100 participants with acute COVID-19 who tested positive for COVID-19 without persistent symptoms defined WHO criteria 3. 50 participants with postural orthostatic tachycardia syndrome (POTS) 4. 50 participants with diabetic neuropathy There are no plans for additional visits at this time. If interested to learn more about this study, please complete the form here for someone to contact you. "here" would take you to the said form.
Study Type
OBSERVATIONAL
Enrollment
300
CND Life Sciences
Scottsdale, Arizona, United States
Pathology and nervous system changes that occur in patients suffering from sensory and autonomic function changes
This is a single site study of subjects with Long COVID, subject with a previous positive COVID test without persistent symptoms, and POTS subjects and diabetics. Neurocutaneous biosignatures will provide insight into the pathology and nervous system changes that occur in patients suffering from sensory and autonomic function changes.
Time frame: Current - December 31,2025
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.